| scholarly article | Q13442814 |
| P50 | author | Maricica Pacurari | Q28050515 |
| Paul B Tchounwou | Q59817484 | ||
| P2093 | author name string | Kenneth Ndebele | |
| Ramzi Kafoury | |||
| P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
| Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin | Q24298747 | ||
| A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule | Q24604026 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries | Q28115126 | ||
| Oral renin inhibitors | Q28269879 | ||
| Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared | Q28289525 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Risk factors for coronary heart disease and acute-phase proteins. A population-based study | Q77850230 | ||
| Angiotensin induces inflammatory activation of human vascular smooth muscle cells | Q77974630 | ||
| Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis | Q78253256 | ||
| Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy | Q82732434 | ||
| Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin | Q82769267 | ||
| IκBNS regulates interleukin-6 production and inhibits neointimal formation after vascular injury in mice | Q82773601 | ||
| Effect of interleukin-6 (IL-6) on the vascular smooth muscle contraction in abdominal aorta of rats with streptozotocin-induced diabetes | Q82777890 | ||
| Prorenin induces vascular smooth muscle cell proliferation and hypertrophy via epidermal growth factor receptor-mediated extracellular signal-regulated kinase and Akt activation pathway | Q83254759 | ||
| Antioxidant activity of peptide-based angiotensin converting enzyme inhibitors | Q83394016 | ||
| Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent | Q83529145 | ||
| Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma | Q83611006 | ||
| Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury | Q93514193 | ||
| Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. | Q50668553 | ||
| Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. | Q53562530 | ||
| Aldosterone impairs bone marrow-derived progenitor cell formation. | Q53611018 | ||
| Human cytokines modulate arterial vascular tone via endothelial receptors. | Q54064427 | ||
| Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors | Q54267978 | ||
| Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. | Q54337264 | ||
| Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. | Q54387733 | ||
| Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. | Q54395386 | ||
| Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. | Q54551007 | ||
| Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. | Q54564514 | ||
| Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. | Q54656142 | ||
| Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. | Q54750642 | ||
| C-Reactive Protein, Interleukin 6, Fibrinogen and Risk of Sudden Death in European Middle-Aged Men: The PRIME Study | Q57605731 | ||
| Multiple Biological Predictors for Vulnerable Carotid Lesions | Q59161764 | ||
| Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors | Q59305166 | ||
| Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy | Q60713394 | ||
| Regulation of aldosterone secretion | Q68142565 | ||
| The renin-angiotensin system (second of two parts) | Q68691226 | ||
| Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension | Q70533705 | ||
| Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II | Q71590987 | ||
| Activation of human peripheral monocytes by angiotensin II | Q71634273 | ||
| Widespread tissue distribution of human chymase | Q72616829 | ||
| Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor | Q72997576 | ||
| Direct proinflammatory effect of C-reactive protein on human endothelial cells | Q73134567 | ||
| Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension | Q73335421 | ||
| Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury | Q74472245 | ||
| Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors | Q77215422 | ||
| Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis | Q77544912 | ||
| Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress | Q28372941 | ||
| Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor | Q28573287 | ||
| Colocalization and release of angiotensin and renin in renal cortical cells | Q30311510 | ||
| (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation | Q30433027 | ||
| Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells | Q30462210 | ||
| The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data | Q30664916 | ||
| Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. | Q31929933 | ||
| Autocrine and paracrine function of Angiotensin 1-7 in tissue repair during hypertension | Q33598406 | ||
| Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. | Q33900223 | ||
| C-reactive protein-mediated vascular injury requires complement. | Q33961757 | ||
| Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. | Q34106420 | ||
| Aliskiren displays long-lasting interactions with human renin | Q34109516 | ||
| Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone | Q34378188 | ||
| Aldosterone Enhances IGF-I-Mediated Signaling and Biological Function in Vascular Smooth Muscle Cells | Q34392644 | ||
| Pathophysiology of coronary artery disease | Q34429470 | ||
| Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. | Q34608252 | ||
| Tumor necrosis factor-α signaling in macrophages. | Q34734335 | ||
| Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans | Q34981416 | ||
| Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis | Q35027751 | ||
| Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system | Q35099152 | ||
| Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. | Q35763936 | ||
| Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit | Q35822869 | ||
| NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells | Q36001842 | ||
| Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension | Q36015782 | ||
| Effect of Alzheimer caregiving on circulating levels of C-reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study | Q36182377 | ||
| STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. | Q36254330 | ||
| The liver as the site of C-reactive protein formation | Q36267987 | ||
| Effects of aldosterone on the vasculature | Q36375830 | ||
| Pathophysiological regulation of the AT1-receptor and implications for vascular disease | Q36443428 | ||
| Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease | Q36511499 | ||
| Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion | Q37003229 | ||
| Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. | Q37098279 | ||
| Renin-angiotensin system revisited | Q37269647 | ||
| The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction. | Q37364037 | ||
| Inflammation in cardiovascular disease: cart, horse, or both? | Q48018364 | ||
| Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation | Q48561334 | ||
| Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis | Q48577521 | ||
| In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. | Q50503323 | ||
| Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt | Q37406166 | ||
| Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats | Q37731722 | ||
| Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted? | Q37786566 | ||
| Endothelial Damage and Regeneration: The Role of the Renin-Angiotensin-Aldosterone System | Q37812341 | ||
| Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials | Q37853688 | ||
| Mineralocorticoid receptors in vascular function and disease | Q37896953 | ||
| Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil | Q37907074 | ||
| Targeting the aldosterone pathway in cardiovascular disease. | Q37951665 | ||
| Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. | Q38054993 | ||
| Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial | Q38483164 | ||
| The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling | Q38571062 | ||
| Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. | Q39673573 | ||
| The renin-angiotensin system (first of two parts). | Q39901718 | ||
| Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice | Q39937826 | ||
| Investigation of aldosterone-synthase inhibition in rats | Q40326702 | ||
| Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies | Q40982204 | ||
| Interleukin-6 overexpression induces pulmonary hypertension | Q41056520 | ||
| Effect of vasoactive peptides on prostacyclin synthesis in man. | Q41776050 | ||
| C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. | Q42460041 | ||
| Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats | Q42785218 | ||
| Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism | Q42908792 | ||
| Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways | Q43052006 | ||
| Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts | Q43203856 | ||
| Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension | Q43630782 | ||
| In vitro evidence for an intracellular site of angiotensin action | Q43819699 | ||
| A specific binding site for the prorenin propart peptide Arg10-Arg20 does not occur on human endothelial cells | Q43856359 | ||
| Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension | Q44119714 | ||
| Presence of cellular renin-angiotensin system in chromaffin cells of bovine adrenal medulla | Q44182982 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle | Q44382946 | ||
| Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action | Q44582536 | ||
| Cooperative interaction between reactive oxygen species and Ca2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes | Q44636719 | ||
| Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease | Q44960467 | ||
| Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis | Q45081308 | ||
| Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. | Q45151827 | ||
| Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study | Q45227732 | ||
| The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance | Q45230899 | ||
| Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function | Q45866740 | ||
| Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension. | Q45925622 | ||
| Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists | Q46378624 | ||
| Aliskiren | Q46434761 | ||
| Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone | Q46513264 | ||
| A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors | Q46687545 | ||
| Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy | Q46878366 | ||
| Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients | Q46947467 | ||
| Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists | Q47746698 | ||
| Direct evidence of leukocyte adhesion in arterioles by angiotensin II. | Q47882328 | ||
| Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women | Q48017162 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 689360 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | International Journal of Inflammation | Q26854008 |
| P1476 | title | The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling | |
| P478 | volume | 2014 |
| Q48171749 | 9c11tCLA modulates 11t18:1 and 9t18:1 induced inflammations differently in human umbilical vein endothelial cells |
| Q47122991 | A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis |
| Q35166507 | Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats |
| Q57493008 | Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
| Q92105261 | Aliskiren Attenuates the Inflammatory Response and Wound Healing Process in Diabetic Mice With Periodontal Disease |
| Q54942300 | Angiotensin Converting Enzyme Inhibitor Has a Protective Effect on Decompression Sickness in Rats. |
| Q50860880 | Angiotensin II degrades myeloid cell leukemia 1 in human umbilical vein endothelial cells. |
| Q92308878 | Angiotensin type 1 receptor regulates yes-associated protein in vascular endothelial cells |
| Q37298852 | Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways |
| Q47156005 | Anti-Atherogenic Activity of Polyphenol-Rich Extract from Bee Pollen. |
| Q42749907 | Anti-proliferative effect of olmesartan on Tenon's capsule fibroblasts |
| Q58700143 | Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from (Rhodophyta) in Spontaneously Hypertensive Rats (SHRs) |
| Q36402889 | Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients |
| Q54241446 | Deregulation of microRNA‑31a‑5p is involved in the development of primary hypertension by suppressing apoptosis of pulmonary artery smooth muscle cells via targeting TP53. |
| Q28082426 | Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on? |
| Q36000085 | Differences in angiotensin (1-7) between men and women |
| Q41064217 | Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia |
| Q41071250 | Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats. |
| Q41665791 | Effect of Angiotensin-converting Enzyme Inhibitor on Cardiac Fibrosis and Oxidative Stress Status in Lipopolysaccharide-induced Inflammation Model in Rats |
| Q35996673 | Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis |
| Q28081614 | Emerging risk biomarkers in cardiovascular diseases and disorders |
| Q37303218 | Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury |
| Q50085156 | Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors |
| Q64977583 | Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells. |
| Q41686212 | Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System. |
| Q38560322 | Giant Cell Arteritis: Beyond Corticosteroids |
| Q41460308 | Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases |
| Q93107829 | Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases |
| Q38707968 | Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia |
| Q40984472 | Increased secretory sphingomyelinase activity in the first trimester of pregnancy in women later developing preeclampsia: a nested case-control study |
| Q92393610 | Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events |
| Q26795756 | Inflammation, oxidative stress and renin angiotensin system in atherosclerosis |
| Q38535519 | Inflammatory markers and cardiometabolic diseases |
| Q89975476 | Integration of Rap1 and Calcium Signaling |
| Q58585770 | Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice |
| Q60046138 | Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells |
| Q47410319 | Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis |
| Q37382499 | Lipopolysaccharide-Induced Spatial Memory and Synaptic Plasticity Impairment Is Preventable by Captopril |
| Q51076687 | Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro-lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells. |
| Q38965333 | Macrophages in neuroinflammation: role of the renin-angiotensin-system. |
| Q87952706 | Maternal high-salt diet alters redox state and mitochondrial function in newborn rat offspring's brain |
| Q64227997 | Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of ATR Initiated by van der Waals Attraction |
| Q89978311 | MiR155-5p Inhibits Cell Migration and Oxidative Stress in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats |
| Q64095748 | Neprilysin Inhibitor-Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice |
| Q37464463 | PGC-1α dictates endothelial function through regulation of eNOS expression |
| Q89566874 | Potassium Homeostasis, Oxidative Stress, and Human Disease |
| Q36579452 | Prenatal inflammation-induced NF-κB dyshomeostasis contributes to renin-angiotensin system over-activity resulting in prenatally programmed hypertension in offspring |
| Q64234882 | Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice |
| Q59238692 | Protective Effect of Polyphenol-Rich Extract from Bee Pollen in a High-Fat Diet |
| Q58785055 | Protein Arginine Methyltransferase 2 Inhibits Angiotensin II-Induced Proliferation and Inflammation in Vascular Smooth Muscle Cells |
| Q35292187 | Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production, and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway |
| Q37713975 | Reactive oxygen species mediate angiotensin II-induced transcytosis of low-density lipoprotein across endothelial cells. |
| Q37680898 | Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting |
| Q38746377 | Relationship between serum sodium level and coronary artery abnormality in Kawasaki disease |
| Q59125636 | Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity |
| Q39006068 | Role of MicroRNA in Endothelial Dysfunction and Hypertension |
| Q35625794 | Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling |
| Q26747017 | Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension |
| Q90605122 | Rosuvastatin reverses hypertension-induced changes in the aorta structure and endothelium-dependent relaxation in rats through suppression of apoptosis and inflammation |
| Q49315105 | Salix alba attenuated oxidative stress in the heart and kidney of hypercholesterolemic rabbits |
| Q88243444 | Senescent cells: a therapeutic target for cardiovascular disease |
| Q26765953 | Signaling Interactions in the Adrenal Cortex |
| Q93105605 | Suboptimal hydration remodels metabolism, promotes degenerative diseases, and shortens life |
| Q40808750 | The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting. |
| Q98289614 | The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases |
| Q51767571 | The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging. |
| Q55024341 | The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus. |
| Q47883642 | The intrauterine renin-angiotensin system: Sex-specific effects on the prevalence of spontaneous preterm birth |
| Q51589303 | The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7). |
| Q26822734 | The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress |
| Q38897552 | The relationship of stress and blood pressure effectors |
| Q38239170 | The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis |
| Q52805890 | The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? |
| Q38419238 | The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). |
| Q36506899 | Threonine532 phosphorylation in ClC-3 channels is required for angiotensin II-induced Cl(-) current and migration in cultured vascular smooth muscle cells |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q38353932 | Vascular smooth muscle cell in atherosclerosis |
Search more.